[go: up one dir, main page]

FI971171L - Kompositioner och förfaranden för behandling av inflammationssjukdomar uppkomna av mastcell - Google Patents

Kompositioner och förfaranden för behandling av inflammationssjukdomar uppkomna av mastcell Download PDF

Info

Publication number
FI971171L
FI971171L FI971171A FI971171A FI971171L FI 971171 L FI971171 L FI 971171L FI 971171 A FI971171 A FI 971171A FI 971171 A FI971171 A FI 971171A FI 971171 L FI971171 L FI 971171L
Authority
FI
Finland
Prior art keywords
compositions
methods
inflammatory diseases
mast cell
mediated inflammatory
Prior art date
Application number
FI971171A
Other languages
English (en)
Finnish (fi)
Other versions
FI971171A0 (sv
Inventor
Ken D Rice
Jeffrey M Dener
Anthony R Gangloff
Elaine Yee-Lin Kuo
Original Assignee
Arris Pharm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arris Pharm Corp filed Critical Arris Pharm Corp
Publication of FI971171L publication Critical patent/FI971171L/sv
Publication of FI971171A0 publication Critical patent/FI971171A0/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215Radicals derived from nitrogen analogues of carbonic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/32Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C271/34Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/18Systems containing only non-condensed rings with a ring being at least seven-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
FI971171A 1994-09-23 1997-03-20 Kompositioner och förfaranden för behandling av inflammationssjukdomar uppkomna av mastcell FI971171A0 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31226994A 1994-09-23 1994-09-23
PCT/US1995/011814 WO1996009297A1 (en) 1994-09-23 1995-09-14 Compositions and methods for treating mast-cell inflammatory condition

Publications (2)

Publication Number Publication Date
FI971171L true FI971171L (sv) 1997-03-20
FI971171A0 FI971171A0 (sv) 1997-03-20

Family

ID=23210670

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971171A FI971171A0 (sv) 1994-09-23 1997-03-20 Kompositioner och förfaranden för behandling av inflammationssjukdomar uppkomna av mastcell

Country Status (25)

Country Link
US (2) US6022969A (sv)
EP (1) EP0782571A1 (sv)
JP (1) JPH10506390A (sv)
KR (1) KR970706267A (sv)
CN (1) CN1160398A (sv)
AU (1) AU694275B2 (sv)
CA (1) CA2200561A1 (sv)
CZ (1) CZ87097A3 (sv)
EE (1) EE03525B1 (sv)
FI (1) FI971171A0 (sv)
HR (1) HRP950499B1 (sv)
HU (1) HUT77770A (sv)
IL (1) IL115405A (sv)
LT (1) LT4234B (sv)
LV (1) LV11865B (sv)
MX (1) MX9702125A (sv)
NO (1) NO309605B1 (sv)
NZ (1) NZ294392A (sv)
PL (1) PL183552B1 (sv)
RU (1) RU2159229C2 (sv)
SI (1) SI9520101A (sv)
SK (1) SK37997A3 (sv)
TW (1) TW442478B (sv)
WO (1) WO1996009297A1 (sv)
ZA (1) ZA958028B (sv)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK8599A3 (en) * 1996-07-30 2000-03-13 Arris Pharm Corp Disubstituted cyclic compound, process for its preparation, pharmaceutical composition and method of the treatment of an animal
WO1998024886A1 (en) * 1996-12-04 1998-06-11 Brigham And Women's Hospital, Inc. Mast cell protease that cleaves fibrinogen
WO1998033812A1 (en) * 1997-02-05 1998-08-06 Brigham And Women's Hospital, Inc. Mast cell protease peptide inhibitors
WO1999012918A1 (fr) * 1997-09-05 1999-03-18 Yoshitomi Pharmaceutical Industries, Ltd. Inhibiteur de la tryptase
AU1208999A (en) * 1997-11-10 1999-05-31 Array Biopharma, Inc. Compounds which inhibit tryptase activity
US6221914B1 (en) 1997-11-10 2001-04-24 Array Biopharma Inc. Sulfonamide bridging compounds that inhibit tryptase activity
US6613769B1 (en) 1998-02-06 2003-09-02 Max-Planck-Gesellschaft zur Föderung der Wissenschaften. e.V. Tryptase inhibitors
WO1999040083A2 (de) * 1998-02-06 1999-08-12 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Bifunktionelle tryptase-inhibitoren
JP2003524598A (ja) * 1998-09-04 2003-08-19 アルタナ ファルマ アクチエンゲゼルシャフト 新規ピラノセン
US6362216B1 (en) 1998-10-27 2002-03-26 Array Biopharma Inc. Compounds which inhibit tryptase activity
US7704958B1 (en) * 1999-03-05 2010-04-27 Bio Holding, Inc. Methods and compositions for inhibiting apoptosis using serine protease inhibitors
US6849605B1 (en) * 1999-03-05 2005-02-01 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of viral infections
CN1378538A (zh) * 1999-08-10 2002-11-06 比克·古尔顿·劳姆贝尔格化学公司 二氮芳辛-二酮衍生物及其作为类胰蛋白酶抑制剂的应用
DE19940389A1 (de) * 1999-08-25 2001-03-01 Wilex Biotechnology Gmbh Selektive Inhibitoren des Urokinase-Plasminogen Aktivators
WO2001019809A1 (en) * 1999-09-14 2001-03-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Tryptase inhibitors
GB9923710D0 (en) * 1999-10-08 1999-12-08 Proteus Molecular Design Chemical compounds
AU1413301A (en) * 1999-11-17 2001-05-30 Sumitomo Pharmaceuticals Company, Limited Diabetic remedy containing dipiperazine derivative
ES2222270T3 (es) * 1999-12-20 2005-02-01 Altana Pharma Ag Inhibidores de triptasa.
PT1244643E (pt) * 1999-12-20 2004-10-29 Altana Pharma Ag Inibidores da triptase
WO2001052883A1 (en) * 2000-01-20 2001-07-26 Amgen Inc. Inhibitors of protease-activated receptor-2 (par-2) as novel asthma therapeutics
US20020045613A1 (en) * 2000-04-27 2002-04-18 Heinz Pauls 1-aroyl-piperidinyl benzamidines
CA2438594A1 (en) 2001-01-31 2002-08-08 Altana Pharma Ag Diazocine derivatives and their use as tryptase inhibitors
US7060716B2 (en) 2001-02-21 2006-06-13 Altana Pharma Ag Tryptase inhibitors
DE60220504T2 (de) * 2001-02-21 2008-02-14 Nycomed Gmbh Tryptasehemmer
AU2002254941B2 (en) * 2001-03-15 2007-05-17 Altana Pharma Ag Tryptase-inhibitors
WO2002074732A2 (en) * 2001-03-15 2002-09-26 Altana Pharma Ag Tryptase-inhibitors
US7232924B2 (en) * 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
EP1401809B1 (en) 2001-06-19 2006-12-20 ALTANA Pharma AG Tryptase inhibitors
AU2002352382A1 (en) * 2001-12-13 2003-06-23 Kowa Company Ltd Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity
EP1483241A4 (en) 2002-03-08 2006-12-13 Bristol Myers Squibb Co CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
TW200524849A (en) * 2003-07-02 2005-08-01 Hoffmann La Roche Hydroxyalkylamide derivatives
US20050255154A1 (en) * 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
TW200815351A (en) * 2006-05-02 2008-04-01 Astrazeneca Ab Novel compounds
TWI414527B (zh) * 2010-10-06 2013-11-11 Ind Tech Res Inst 異山梨糖醇衍生物及包含該衍生物之液晶顯示器
CN102453037B (zh) * 2010-10-25 2014-06-25 财团法人工业技术研究院 异山梨糖醇衍生物及包含该衍生物的液晶显示器

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR208414A1 (es) * 1974-11-07 1976-12-27 Rhone Poulenc Ind Procedimiento para obtener nuevos derivados de la((acil-4piperazinil-1)carboniloxi-5 pirrolinona-2)
US4746737A (en) * 1985-07-26 1988-05-24 Kowa Co., Ltd. Phenyl guanidinobenzoate derivatives which have protease inhibitory activity
NZ263084A (en) * 1993-03-12 1997-08-22 Arris Pharm Corp Dipeptide derivatives, treatment of immunomediated inflammatory disorders
JPH08507768A (ja) * 1993-03-12 1996-08-20 アリス ファーマシューティカル コーポレイション 免疫仲介炎症疾患の処置のための組成物および方法
AU2764495A (en) * 1994-06-01 1995-12-21 Arris Pharmaceutical Corporation Compositions and methods for treating mast-cell mediated conditions

Also Published As

Publication number Publication date
IL115405A0 (en) 1995-12-31
NZ294392A (en) 1999-05-28
TW442478B (en) 2001-06-23
AU694275B2 (en) 1998-07-16
SK37997A3 (en) 1998-12-02
SI9520101A (en) 1997-12-31
KR970706267A (ko) 1997-11-03
MX9702125A (es) 1998-04-30
CZ87097A3 (en) 1997-11-12
EE9700089A (et) 1997-10-15
FI971171A0 (sv) 1997-03-20
CA2200561A1 (en) 1996-03-28
NO309605B1 (no) 2001-02-26
LT97065A (en) 1997-08-25
NO971305D0 (no) 1997-03-20
JPH10506390A (ja) 1998-06-23
EP0782571A1 (en) 1997-07-09
US6022969A (en) 2000-02-08
US6211228B1 (en) 2001-04-03
HRP950499A2 (en) 1997-08-31
HRP950499B1 (en) 2003-04-30
EE03525B1 (et) 2001-10-15
HUT77770A (hu) 1998-08-28
IL115405A (en) 2002-07-25
NO971305L (no) 1997-05-06
AU3718095A (en) 1996-04-09
PL183552B1 (pl) 2002-06-28
CN1160398A (zh) 1997-09-24
WO1996009297A1 (en) 1996-03-28
ZA958028B (en) 1996-04-18
LV11865A (lv) 1997-10-20
LV11865B (en) 1998-01-20
PL319587A1 (en) 1997-08-18
RU2159229C2 (ru) 2000-11-20
LT4234B (en) 1997-10-27

Similar Documents

Publication Publication Date Title
FI971171L (sv) Kompositioner och förfaranden för behandling av inflammationssjukdomar uppkomna av mastcell
FI972781L (sv) Förfarande och kompositioner för behandling av allergenisk snuva och andra sjukdomar genom användning av de karboetoxyloratadien
FI971969A0 (sv) Kompositioner för behandling av hemorrojder och användningsmetod
GR3036364T3 (en) Compositions and methods for treating or preventing inflammatory diseases
FI964536L (sv) DNA-struktur för genomförande av homolog rekombination och användningar därav
FI973074A0 (sv) Bakförfarande och därtill hörande anordning
IL132758A0 (en) Methods for treating inflammation and inflammatory diseases using padprt
BR9506031A (pt) Método para evitar o levantamento de pó
ITMI950529A0 (it) Composizioni farmaceutiche e procedimento per la loro preparazione
EE9800459A (et) Spiro-piperidiini derivaadid ja nende kasutamine terapeutiliste toimeainetena
FI943625A0 (sv) Förfaranden för behandling av inflammatoriska hudsjukdomar
FI970079L (sv) Fungicid komposition och förfarande för kontroll av svampinfektion
FI964162L (sv) Ämnessammansättning och förfarande för reglering av växtsjukdomar
FI970534L (sv) Förfaranden och kompositioner som är användbara vid profylax och behandling av endotoxinrelaterade tillstånd
FI951060L (sv) Formulationer och behandlingsmetoder
FI965008L (sv) Sammansättningar och förfaranden för tumörbehandling
BR9508110A (pt) Derivado de triterpeno e composição médica
IT1279089B1 (it) Assieme di attuatore da usarsi in apparecchiature
BR9510062A (pt) Macromonômeto esterificado e composição
DE69520998D1 (de) Faserbehandlungszusammensetzungen
FI954245A0 (sv) Kompositioner och metoder för behandling av immunförmedlade inflammatoriska rubbningar
FI971138L (sv) Keramiska isolatorer och förfaranden för deras framställning
ATE222058T1 (de) Backtriebsäurezusammensetzung
FI942298A0 (sv) Förfarande och anordning för förflyttning av rumselementer
FR2724699B1 (fr) Ecrou